NO BCG available from the Nassau County Department of Health and NYC Dep't of Health
Afterall it is safe, inexpensive and effective for a a variety of purposes, see eg faustmanlab.org
pubmed.org faustman dl and pubmed.org ristori bcg
there are no cases of asthma and allergy in Manhattan.
>>> Rigshospitalet <news@meltwaterpress.com> 9/3/2012 9:27 AM >>>
 Press release |
3rd of September 2012 |
Tuberculosis vaccine - a new remedy for allergies and asthma in children? M Can a vaccine against tuberculosis help combat asthma and eczema in Danish children early in life? This will now be examined in a comprehensive Danish research study. From September 2012, thousands of Danish pregnant women will receive an invitation to allow their newborns to take part in a sensational trial. The tuberculosis vaccine was removed from the vaccine program in Denmark during the 1980s, however new research indicates that the vaccine can improve the health of children. Research carried out in developing countries shows that the health of infants who have been given the tuberculosis vaccine (BCG/Calmette) at birth is improved and the babies have a better survival rate than those who have not been given the vaccine. The vaccine also seems to have a preventive effect against asthma and atopic dermatitis. Results are so striking that they cannot be explained by the fact that the children did not catch tuberculosis. Therefore, researchers assess the vaccine to have a general positive effect on the immune system, which means that children are less sick, and have less atopic dermatitis, asthma and allergies. Whether this positive effect also can benefit Danish children will now be examined in a large Danish research project headed by Lone Graff Stensballe, Paediatrician from the Department of Paediatrics and Adolescent Medicine at Rigshospitalet. The research project will run for three years, starting in September 2012, where 4,300 infants and their parents will be followed through interviews, examinations, and, for 300 of the children, blood tests as well. The project will comprise five PhD courses and a research collaboration with obstetricians, paediatricians, midwives, nurses and laboratory technicians from the three hospitals taking part in the project. “We are very excited about this unique opportunity to improve the health of Danish children early in life,” says Lone Graff Stensballe. “Unfortunately, we have seen large increases in admissions, consumption of medicines, asthma, eczema and allergies among Danish children. We hope to curb these increases with the new research project.” The research project will be carried out at Rigshospitalet in collaboration with Hvidovre Hospital, Kolding Sygehus Lillebælt and the new Centre for Vitamins and Vaccines at SSI (Statens Serum Institut). For further information and interviews, please contact: Lone Graff Stensballe Head of Research Paediatrician, Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Denmark Telephone: +45 6022 8092 E-mail: lone.graff.stensballe@rh.regionh.dk |
For years doctors have warned of a rising epidemic of diabetes among children. Yet there has been surprisingly little firm data on the extent of this disease among younger Americans.
Now a nationally representative study has confirmed that from 2001 to 2009 the incidence of Type 1 and Type 2 diabetes drastically increased among children and adolescents across racial groups.
The prevalence of Type 1 diabetes
increased 21 percent among children up to age 19, the study found. The
prevalence of Type 2 diabetes among those ages 10 to 19 rose 30 percent
during the period.
Those
are “big numbers,” said Dr. Robin S. Goland, a co-director of the Naomi
Berrie Diabetes Center at Columbia University Medical Center in New
York, who has been in practice for about 25 years. “In my career, Type 1
diabetes was a rare disease in children, and Type 2 disease didn’t
exist. And I’m not that old.”
The
analysis, published on Saturday in JAMA, the journal of the American
Medical Association, includes data from more than three million children
younger than 20 in five states — California, Colorado, Ohio, South
Carolina and Washington — as well as from selected American Indian
reservations.
The
research was funded by the Centers for Disease Control and Prevention
and the National Institutes of Health and is part of a continuing study,
Search for Diabetes in Youth, examining the condition among children.
In Type 1 diabetes, a patient’s immune system attacks cells in the pancreas that make insulin, a hormone required to control blood sugar levels. Historically, children affected by the disease were more often white.
But
the new report found the prevalence also has increased among black and
Hispanic youths. The greatest increase occurred among 15- to
19-year-olds.
“I
don’t understand the basis for an increase,” said Dr. Goland, who was
not involved in the research. “There are a few possibilities, but we
need to figure it out if it’s something in the environment or something
in our genes.”
Some
minority youths are far less likely to control their high blood sugar,
and more likely to have complications like eye disease, kidney disease,
heart disease and amputations, said Dr. Dana Dabelea, the lead author of
the new study and a professor of epidemiology and pediatrics at the
Colorado School of Public Health. She called the increase in Type 1
diabetes among these children “particularly worrisome.”
Type
2 diabetes used to be called “adult-onset” diabetes because it was so
unusual in children. It is thought to be brought on by a genetic
predisposition to poor insulin action and secretion, often exacerbated
by obesity
and inactivity. The new analysis reported increases among black, white
and Hispanic children, but not among Asian-Pacific Islander and American
Indian children.
The
study’s authors speculated that the uptick in Type 2 diabetes may
result from “minority population growth, obesity, exposure to diabetes
in utero and perhaps endocrine-disrupting chemicals.”
The
increase will have public health consequences, the researchers said.
More children will enter adulthood at increased risk of early
complications, and diabetes is harder to treat in children than in adults. Younger patients also still have reproductive years ahead of them.
“Diabetes in pregnancy is a risk factor for diabetes in the next generation,” Dr. Dabelea said.
No comments:
Post a Comment